Corticolimbic circuitry as a druggable target in schizophrenia spectrum disorders: a narrative review
Translational Psychiatry · 24.01.2025 · 15 (1)
DOI: 10.1038/s41398-024-03221-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Translational Psychiatry, online erschienen am 24.01.2025. Verfasst von Abigail Gee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom. Hauptthemen laut MEDLINE: Schizophrenia, Limbic System, Cerebral Cortex, Antipsychotic Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 258 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, Wellcome Trust (Wellcome).
Abstract (Originalsprache)
Schizophrenia spectrum disorders (SSD) involve disturbances in the integration of perception, emotion and cognition. The corticolimbic system is an interacting set of cortical and subcortical brain regions critically involved in this process. Understanding how neural circuitry and molecular mechanisms within this corticolimbic system may contribute to the development of not only positive symptoms but also negative and cognitive deficits in SSD has been a recent focus of intense research, as the latter are not adequately treated by current antipsychotic medications and are more strongly associated with poorer functioning and long-term outcomes. This review synthesises recent developments examining corticolimbic dysfunction in the pathophysiology of SSD, with a focus on neuroimaging advances and related novel methodologies that enable the integration of data across different scales. We then integrate how these findings may inform the identification of novel therapeutic and preventive targets for SSD symptomatology. A range of pharmacological interventions have shown initial promise in correcting corticolimbic dysfunction and improving negative, cognitive and treatment-resistant symptoms. We discuss current challenges and opportunities for improving the still limited translation of these research findings into clinical practice. We argue how our knowledge of the role of corticolimbic dysfunction can be improved by combining multiple research modalities to examine hypotheses across different spatial and temporal scales, combining neuroimaging with experimental interventions and utilising large-scale consortia to advance biomarker identification. Translation of these findings into clinical practice will be aided by consideration of optimal intervention timings, biomarker-led patient stratification, and the development of more selective medications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
- Departments of Neuroscience, Psychiatry and Psychology, University of Pittsburgh, Pittsburgh, PA, USA.
- Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom. gemma.modinos@kcl.ac.uk.
- MRC Centre for Neurodevelopmental Disorders, King's College London, London, UK. gemma.modinos@kcl.ac.uk.
Förderung
- NIMH NIH HHS
- Wellcome Trust (Wellcome)
Zitieren
APA
Gee, A., Dazzan, P., Grace, A. A., & Modinos, G. (2025). Corticolimbic circuitry as a druggable target in schizophrenia spectrum disorders: a narrative review. Translational Psychiatry, 15(1). https://doi.org/10.1038/s41398-024-03221-2
Vancouver
Gee A, Dazzan P, Grace AA, Modinos G. Corticolimbic circuitry as a druggable target in schizophrenia spectrum disorders: a narrative review. Translational Psychiatry. 2025;15(1). doi:10.1038/s41398-024-03221-2
BibTeX
@article{Gee2025,
author = {Gee, Abigail and Dazzan, Paola and Grace, Anthony A and Modinos, Gemma},
title = {Corticolimbic circuitry as a druggable target in schizophrenia spectrum disorders: a narrative review},
journal = {Translational Psychiatry},
year = {2025},
volume = {15},
number = {1},
doi = {10.1038/s41398-024-03221-2}
}
EUVIMED